热门资讯> 正文

Acurx Pharmaceuticals GAAP每股收益为-1.89美元

2025-08-12 19:10

Acurx Pharmaceuticals press release (NASDAQ:ACXP): Q2 GAAP EPS of -$1.89.
The company ended the quarter with cash totaling $6.1 million, compared to $3.7 million as of December 31, 2024.

More on Acurx Pharmaceuticals

Acurx Pharmaceuticals files $50M mixed shelf offering
Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
Historical earnings data for Acurx Pharmaceuticals
Financial information for Acurx Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。